Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology | Immunology | Family Medicine
 Disease Category: Atopic Dermatitis
Location: United States, PA

Trial Information

Atopic Dermatitis

A Randomized, Double blind, placebo controlled, parallel group study of the safety and efficacy of 1% and 2% Nanocrystalline Silver cream ( NPI 32101) applied twice daily in Pediatric and adolescent subjects with mild to moderate atopic dermatitis(AD)

Inclusion Criteria:

  • Age- 2 to 17 years
  • Mild to moderate atopic dermatitis
  • Body surface area involved must be between 5 and 40%

Hirak B. Routh, MBBS
Paddington Testing Co., Inc
1760 Market Street
Suite 301
Philadelphia, PA 19103
Phone: 215 563 7330
Fax: 215 563 9405
Email: larryderm@yahoo.com

View Map

Research Center Information: Paddington Testing Co., Inc

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.